FGFR Inhibitors for Treatment of Primary CNS TumorsBySydney E. Schultz, PharmD,Jason N. Barreto, PharmD,Carolyn Mead-Harvey, MS,Bryan Neth, MD, Samantha Caron, PA,Michael Ruff, MD,Joon Uhm MD,Susan Geyer PhD,Ugur Sener, MDJune 22nd 2026This abstract was presented at the Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, from June 18 to 19, 2026.